跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB COMBIX 3,5 MG POLVO PARA SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BORTEZOMIB COMBIX 3,5 MG POLVO PARA SOLUCIÓN INYECTABLE EFG
Approved
STANDARD
BORTEZOMIB COMBIX 3,5 MG POLVO PARA SOLUCIÓN INYECTABLE EFG
Laboratorios Combix S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 8, 2021
Approval ID
413e7e9345690daa
Company
Laboratorios Combix S.L.U.
Type
Standard
Approval Details
Approval Id
413e7e9345690daa
Drug Cima Aemps Name
BORTEZOMIB COMBIX 3,5 MG POLVO PARA SOLUCIÓN INYECTABLE EFG
Register Number
86314
Holder Company Name
Laboratorios Combix S.L.U.
Marketing Company Name
Laboratorios Combix S.L.U.
Authorization Date
2021-10-08
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
3,5 mg
Route Of Administration
VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Laboratorios Combix S.L.U.
Active Ingredients
BORTEZOMIB
Equivalente a 3.5 mg mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 8, 2021
Approval ID
413e7e9345690daa
Type
Standard
Back to CIMA-AEMPS Approvals